UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025372
Receipt number R000029170
Scientific Title Comparison of antihypertensive medical care using telemedicine vs. conventional therapy
Date of disclosure of the study information 2016/12/25
Last modified on 2021/01/31 16:01:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of antihypertensive medical care using telemedicine vs. conventional therapy

Acronym

Telemedicine comparison trial for hypertension

Scientific Title

Comparison of antihypertensive medical care using telemedicine vs. conventional therapy

Scientific Title:Acronym

Telemedicine comparison trial for hypertension

Region

Japan


Condition

Condition

Essential Hypertension

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Compare by achieved home blood pressure a conventional hypertensive medical care with telemedicine care using ICT-based non-face-to-face communication

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Home blood pressure after 1 year

Key secondary outcomes

1) Major adverse cardiovascular events (coronary events, hospitalization for heart failure, stroke, doubling of serum creatinine)
2) Adverse events
3) Vascular indices: Cardio-Ankle Vascular Index (CAVI), Augmentation Index (AI), Flow Mediated Dilation (FMD), Intima-Media Thickness (IMT), visceral fat area (DUALSCAN)
4) Laboratory data (blood and urine)
5) Questionnaires on quality of life and adherence


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Telemedicine group: after the initial assessment including a face-to-face interview, the participants will use network-attached sphigmomanometer to measure home blood pressure and consult physician by non-face-to-face communcation to adjust antihypertensive treatment for 12 months

Interventions/Control_2

Conventional therapy group will manually measure and record home blood pressure and visit clinics regularly to adjust antihypertensive treatment. The conventional therapy group will be compared to the intervention group after 1 year.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Able to visit Tokyo Women's Medical University Hospital Department of Endocrinology and Hypertension for assessment
2) Wish to try non-face-to-face medical communication and telemedicine
3) Able to perform home blood pressure measurements
4) Age of 20 years or older at time of consent
5) Those with essential hypertension

Key exclusion criteria

1) Those who do not own a smartphone compatible with the telemedicine platform
2) Past history of coronary diseases
3) Those with diabetes mellitus, chronic kidney disease, history of stroke, or peripheral artery disease
4) Those classified as Category III according to the cardiovascular risk chart by Japan Atherosclerosis Society
5) Pregnant women and those with high possibility of becoming pregnant
6) Secondary hypertension, excluding idiopathic hyperaldosteronism and primary aldosteronism after adrenalectomy
7) Those judged by research administrator to be inappropriate for the study

Target sample size

450


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsuhiro Ichihara

Organization

Tokyo Women's Medical University

Division name

Department of Medicine II, Endocrinology and Hypertension

Zip code


Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

atzichi@endm.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Junichi Yatabe

Organization

Tokyo Women's Medical University

Division name

Department of Medicine II, Endocrinology and Hypertension

Zip code


Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Homepage URL

https://port-medical-bp.com/twmu-research

Email

jyatabe@endm.twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

PORT Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学病院(東京都)、TM内科クリニック西新宿(東京都)


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 14 Day

Date of IRB

2016 Year 06 Month 14 Day

Anticipated trial start date

2017 Year 01 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 22 Day

Last modified on

2021 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029170